ABCE1 Regulates RNase L-Induced Autophagy during Viral Infections.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
18 02 2021
Historique:
received: 22 01 2021
revised: 14 02 2021
accepted: 16 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 13 8 2021
Statut: epublish

Résumé

Host response to a viral infection includes the production of type I interferon (IFN) and the induction of interferon-stimulated genes that have broad antiviral effects. One of the key antiviral effectors is the IFN-inducible oligoadenylate synthetase/ribonuclease L (OAS/RNase L) pathway, which is activated by double-stranded RNA to synthesize unique oligoadenylates, 2-5A, to activate RNase L. RNase L exerts an antiviral effect by cleaving diverse RNA substrates, limiting viral replication; many viruses have evolved mechanisms to counteract the OAS/RNase L pathway. Here, we show that the ATP-binding cassette E1 (ABCE1) transporter, identified as an inhibitor of RNase L, regulates RNase L activity and RNase L-induced autophagy during viral infections. ABCE1 knockdown cells show increased RNase L activity when activated by 2-5A. Compared to parental cells, the autophagy-inducing activity of RNase L in ABCE1-depleted cells is enhanced with early onset. RNase L activation in ABCE1-depleted cells inhibits cellular proliferation and sensitizes cells to apoptosis. Increased activity of caspase-3 causes premature cleavage of autophagy protein, Beclin-1, promoting a switch from autophagy to apoptosis. ABCE1 regulates autophagy during EMCV infection, and enhanced autophagy in ABCE1 knockdown cells promotes EMCV replication. We identify ABCE1 as a host protein that inhibits the OAS/RNase L pathway by regulating RNase L activity, potentially affecting antiviral effects.

Identifiants

pubmed: 33670646
pii: v13020315
doi: 10.3390/v13020315
pmc: PMC7922175
pii:
doi:

Substances chimiques

ABCE1 protein, human 0
ATP-Binding Cassette Transporters 0
Endoribonucleases EC 3.1.-
2-5A-dependent ribonuclease EC 3.1.26.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R15 AI119980
Pays : United States

Références

J Biol Chem. 2012 Dec 21;287(52):43651-64
pubmed: 23109342
J Biol Chem. 2006 Feb 17;281(7):3773-84
pubmed: 16275648
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7100-5
pubmed: 16627618
J Biol Chem. 2006 Mar 17;281(11):7452-7
pubmed: 16421098
Int J Clin Exp Pathol. 2014 Jan 15;7(2):584-92
pubmed: 24551278
Mol Cell. 2010 Jan 29;37(2):196-210
pubmed: 20122402
Mol Med Rep. 2014 Oct;10(4):1685-90
pubmed: 25070080
PLoS Pathog. 2018 Apr 13;14(4):e1006989
pubmed: 29652922
J Virol. 2012 Oct;86(20):11311-21
pubmed: 22875977
Nat Rev Immunol. 2008 Jul;8(7):559-68
pubmed: 18575461
RNA Biol. 2017 Oct 3;14(10):1279-1285
pubmed: 28498001
Virology. 1980 Feb;101(1):81-90
pubmed: 6243832
J Biol Chem. 2004 Sep 3;279(36):37832-41
pubmed: 15231837
J Biol Chem. 1984 Feb 10;259(3):1731-7
pubmed: 6319408
Int J Mol Sci. 2015 Jul 31;16(8):17611-36
pubmed: 26263979
Curr Opin Virol. 2015 Dec;15:19-26
pubmed: 26231767
J Virol. 2015 Jul;89(13):6633-45
pubmed: 25878106
Eur J Biochem. 1998 Jun 1;254(2):248-55
pubmed: 9660177
Curr Opin Immunol. 2008 Feb;20(1):23-9
pubmed: 18262399
Cell Host Microbe. 2012 Jun 14;11(6):607-16
pubmed: 22704621
mBio. 2014 Feb 25;5(2):e00856-14
pubmed: 24570368
EMBO J. 2011 May 4;30(9):1804-17
pubmed: 21448132
Nat Struct Mol Biol. 2017 May;24(5):453-460
pubmed: 28368393
J Biol Chem. 2007 May 18;282(20):14752-60
pubmed: 17392269
J Mol Biol. 2008 Feb 1;375(5):1329-43
pubmed: 18082768
J Virol. 2013 Aug;87(15):8408-18
pubmed: 23698313
PLoS Pathog. 2013;9(6):e1003474
pubmed: 23825954
J Biol Chem. 2004 Oct 1;279(40):42157-68
pubmed: 15277527
Int J Mol Sci. 2019 Jul 19;20(14):
pubmed: 31330998
mBio. 2016 Mar 29;7(2):e00258
pubmed: 27025250
J Virol. 2002 May;76(10):5251-9
pubmed: 11967338
Cell Host Microbe. 2015 Apr 8;17(4):466-77
pubmed: 25816776
Int J Mol Med. 2010 May;25(5):687-93
pubmed: 20372810
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13114-9
pubmed: 23878220
J Virol. 2007 Jun;81(11):5561-72
pubmed: 17344297
mBio. 2019 May 14;10(3):
pubmed: 31088929
mBio. 2014 Jul 01;5(4):e01312-14
pubmed: 24987090
Cancer Res. 2004 Dec 15;64(24):9144-51
pubmed: 15604285
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3228-33
pubmed: 21292982
Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):381-8
pubmed: 17681844
J Biol Chem. 2004 Jan 9;279(2):1123-31
pubmed: 14570908
Viruses. 2020 Feb 04;12(2):
pubmed: 32033097
Nucleic Acids Res. 2011 Sep 1;39(17):7750-63
pubmed: 21666256
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6
pubmed: 26858407
Cell. 2005 Jan 28;120(2):159-62
pubmed: 15680321
Cancer Res. 2003 Oct 15;63(20):6795-801
pubmed: 14583476
Mol Cell. 2003 Nov;12(5):1173-85
pubmed: 14636576
J Virol. 1992 Mar;66(3):1602-9
pubmed: 1310768
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
pubmed: 17717517
J Virol. 2007 Dec;81(23):12720-9
pubmed: 17804500
J Virol. 2007 Apr;81(7):3455-64
pubmed: 17229694
J Virol. 1985 Dec;56(3):1041-4
pubmed: 2415713
Cytokine. 2020 Sep;133:153847
pubmed: 27595182
J Virol. 2020 Jun 16;94(13):
pubmed: 32295917
Biochimie. 2012 May;94(5):1098-107
pubmed: 22285541
Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):351-61
pubmed: 17681872
Nature. 2002 Jan 3;415(6867):88-92
pubmed: 11780123
Mol Cell. 2014 Jan 23;53(2):221-34
pubmed: 24462203
Nat Rev Drug Discov. 2007 Dec;6(12):975-90
pubmed: 18049472
Autophagy. 2008 Jan;4(1):131-4
pubmed: 18000393
J Virol. 2018 Apr 13;92(9):
pubmed: 29467316
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14533-8
pubmed: 16203993
Nature. 2007 Aug 16;448(7155):816-9
pubmed: 17653195
Traffic. 2007 Mar;8(3):195-211
pubmed: 17233757
Methods Mol Biol. 2001;160:183-98
pubmed: 11265282
J Biol Chem. 2015 Aug 7;290(32):19681-96
pubmed: 26055709
Eur J Biochem. 1984 Aug 15;143(1):165-74
pubmed: 6088228
J Virol. 1999 Jan;73(1):290-6
pubmed: 9847332
J Biol Chem. 1995 Jun 2;270(22):13308-17
pubmed: 7539425
BMC Mol Biol. 2006 Jan 31;7:3
pubmed: 16448564

Auteurs

Barkha Ramnani (B)

Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA.

Praveen Manivannan (P)

Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA.

Sarah Jaggernauth (S)

Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA.

Krishnamurthy Malathi (K)

Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH